Refractory Prostate Carcinoma

general

Prostate carcinoma that is resistant to treatment.

10

Centers

10

Active Trials

Cancer Funding

Top Centers for Refractory Prostate Carcinoma(10)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
55.0
2
NCI Comprehensive
Active Research Program
55.0
3
NCI Comprehensive
Active Research Program
55.0
4
NCI Comprehensive
Active Research Program
55.0
5
NCI Comprehensive
Active Research Program
55.0
6
NCI Clinical
Active Research Program
55.0
7
Active Research Program
55.0
8
Active Research Program
55.0
9
Active Research Program
55.0
10
Active Research Program
55.0

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →